Forest Laboratories, Inc.

Forest Laboratories, Inc. (United States) holds 0 active US FDA Type II Drug Master Files and 18 inactive, has DMF or CEP filings on record for 2 active ingredients and holds 0 active Type IV (excipient) Drug Master Files. 1 FDA enforcement record is linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Forest Laboratories, Inc.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/forest-laboratories-inc

Overview

Forest Laboratories, Inc. was a pharmaceutical company focused on the development, manufacturing, and sale of branded forms of ethical drug products, which require a physician's prescription. It is now a subsidiary of Allergan Inc. after the acquisition in 2014.

Therapeutic areas

Active ingredients with DMF or CEP filings

Substances for which Forest Laboratories, Inc. holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Forest Laboratories, Inc. holds 0 active (18 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • FACILITIES UTILIZED IN ST. LOUIS, MOInactive1989-01-03
  • SODIUM MONOFLUOROPHOSPHATE 76 MG. C.R. TABLETSInactive1987-08-28
  • FACILITIES AND PERSONNEL IN RIO PIEDRAS, PUERTO RICOInactive1987-04-28
  • THIORIDAZINE HCL. 50MG.C.R.TABLETSInactive1985-09-06
  • QUINIDINE GLUCONATE 650 MG. C.R. TABLETSInactive1985-07-01
  • ERYTHROMYCIN 500MG. C.R.TABLETSInactive1985-06-03
  • PENTAERYTHRITOL TETRANITRATE (P.E.T.N.) 80mg. & 160mg C.R. TABLETSInactive1985-05-13
  • THIORIDAZINE HCL 400MG S.R.TABS (IN SYNCHRON VEHICLE)Inactive1985-02-14
  • THIORIDAZINE HCL 200 MG C.R. TABS (IN SYNCHRON VEHICLE)Inactive1984-11-28
  • FLURBIPROFEN 100 MG C.R.TABS (IN SYNCHRON VEHICLEInactive1983-10-26
  • FLURBIPROFEN 200 mg C.R. TABS (IN SYNCHRON VEHICLEInactive1983-10-26
  • IBUPROFEN 800 MG C.R. TABLETS (IN SYNCHRON VEHICLE)Inactive1982-09-02
  • THIORIDAZINE HCl C.R. TABLETS (IN SYNCHRON VEHICLE)Inactive1982-07-27
  • THIORIDAZINE HCL100MG CR(LD IN SYCHRON VEHICLE)MNFG INWOOD,NYInactive1982-07-27
  • SODIUM FLUORIDE 22MG, SUSTAINED ACTION CAPSULESInactive1981-10-08
  • CAPTOPRIL-S 250MG C.R. TABLETSInactive1979-12-05
  • CAPTOPRIL-F 250MG C.R. TABLETSInactive1979-12-05
  • MANUFACTURING SITE,FACILITIES,OPERATING PROCEDURES, AND PERSONNEL.Inactive1970-12-16

Excipient Drug Master Files

Forest Laboratories, Inc. holds 0 active (1 total) FDA Type IV Drug Master File. A Type IV DMF covers an excipient, colourant or flavour, not an active ingredient; these are counted separately from the API filings above.

  • SYNCHRON ORAL-CARRIERInactive1975-10-03

FDA compliance signals

1 FDA enforcement record linked to this company.

  • recall — Class II2017-06-07

    Labeling; Label Mixup; blister lidding foil and shell-pack labeled as 10 mg but package actually contains 5 mg tablets

For suppliers

Is this Forest Laboratories, Inc.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.